ACS (excluding AMI): 2 trials - STAI - Florida UA
| ticlopidine vs control | No demonstrated result suggested cardiovascular events by 48% (not demonstrated) | |
| ticlopidine vs placebo | No demonstrated result |
All type of patients: 1 trials - Knudsen-A
| ticlopidine vs control | No demonstrated result |
All type of patients: 6 trials - Liège-I - Liège-II - Zurich - Knudsen-B - Romeo - Kohn
| ticlopidine vs control | No demonstrated result | |
| ticlopidine vs placebo | No demonstrated result |
Diabetic patients : 5 trials - Birmingham-A - London diabetes - TIMAD - BTRS - Nyberg
| ticlopidine vs placebo | No demonstrated result |
All type of patients: 1 trials - Berglund
| ticlopidine vs placebo | No demonstrated result |
All type of patients: 5 trials - Birmingham-A - London diabetes - TIMAD - BTRS - Nyberg
| ticlopidine vs placebo | No demonstrated result |
All type of patients: 7 trials - FANTASTIC - ISAR - Foussas - MATTIS - STARS (vs coumadin+asp) - STARS (vs aspirin) - Hall
| ticlopidine + aspirin vs aspirin | No demonstrated result suggested MACE by 73% (not demonstrated) | |
| ticlopidine + aspirin vs coumadin + aspirin | No demonstrated result suggested MACE by 59% (not demonstrated) |
After revascularisation: 1 trials - Becquemin
| ticlopidine vs contrôle | No demonstrated result |
All type of patient: 1 trials - Berglund
| ticlopidine vs placebo | No demonstrated result |
All type of patients: 7 trials - FANTASTIC - ISAR - Foussas - MATTIS - STARS (vs coumadin+asp) - STARS (vs aspirin) - Hall
| ticlopidine + aspirin vs aspirin | No demonstrated result suggested MACE by 73% (not demonstrated) | |
| ticlopidine + aspirin vs coumadin + aspirin | No demonstrated result suggested MACE by 59% (not demonstrated) |
All type of patients: 5 trials - Lasierra - Walker - McKenna-II - Lyon-II - Gardecki
| ticlopidine vs placebo | No demonstrated result |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
